Sinonasal Hemangiopericytomas
Sinonasal hemangiopericytomas (HPCs) are a rare type of tumor that occur in the head and neck region. While up to 25 percent of all hemangiopericytomas are found in this area, only one percent of sinonasal tumors are diagnosed as HPCs. These tumors typically develop in individuals in their sixties and seventies and are characterized by symptoms such as nasal obstructions or nasopharyngeal hemorrhages.
What sets HPCs apart from other tumors is their origin in muscle tissue rather than around blood vessels. This unique characteristic distinguishes them from other sinonasal tumors. Despite their rarity and distinct nature, surgery is often successful in completely removing HPCs in the majority of cases. Recurrence and metastasis of HPCs are uncommon.
The Endoscopic Endonasal Approach: A Minimally Invasive Treatment for Difficult Head and Neck Hemangiopericytomas
When it comes to treating challenging head and neck hemangiopericytomas, such as sinonasal tumors, doctors often opt for the endoscopic endonasal approach (EEA). This minimally invasive treatment involves the insertion of an endoscope into the nose and sinus cavities. By providing the surgeon with a clear image of the tumor and its surrounding area, the endoscope allows for precise removal of the mass and any affected tissue. One of the significant advantages of this method is the absence of a facial incision, resulting in reduced recovery time and trauma for the patient.